Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer

Journal of Clinical Oncology

Volumn 24, Issue 33, 2006, Pages 5330-5331

  Tolaney, Sara M ^a   Partridge, Ann H ^a   Sheib, Rochelle G ^a   Burstein, Harold J ^a   Winer, Eric P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; LEVOQUIN; PACLITAXEL; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG DOSE REGIMEN; FEMALE; FEVER; HUMAN; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; POSTMENOPAUSE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PAGET NIPPLE DISEASE;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FEMALE; FEVER; FILGRASTIM; HUMANS; MIDDLE AGED; NEUTROPENIA; PACLITAXEL; PNEUMONIA, PNEUMOCYSTIS; PREDNISONE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 34247377703     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.1083     Document Type: Article

References (13)

1. Sepkowitz KA: Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 34:1098-1107, 2002
2. Sepkowitz KA, Brown AE, Telzak EE, et al: Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267:832-837, 1992
3. Yale SH, Limper AH: Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5-13, 1996
4. Kane GC, Troshinsky MB, Peters SP, et al: Pneumocystis carinii pneumonia associated with weekly methotrexate: Cumulative dose of methotrexate and low CD4 cell count may predict this complication. Respir Med 87:153-155, 1993
5. Siminski J, Kidd P, Phillips GD, et al: Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia. Am Rev Respir Dis 143:437440, 1991
6. Kulke MH, Vance EA: Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 25:215-218, 1997
7. Mackall CL, Fleisher TA, Brown MR, et al: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221-2228, 1994
8. Norton L: Conceptual and practical implications of breast tissue geometry: Toward a more effective, less toxic therapy. Oncologist 10:370-381, 2005
9. Burstein HJ, Parker LM, Keshaviah A, et al: Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol 23:8340-8347, 2005
10. Sepkowitz KA: Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin Respir Infect 7:114-121, 1992
11. Worth LJ, Dooley MJ, Seymour JF, et al: An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer 92:867-872, 2005
12. Mansharamani NG, Balachandran D, Vernovsky I, et al: Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 118:712-720, 2000
13. Citron ML, Berry DA, Cirrincione C, et al: Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21:1431-1439, 2003